| 000 | 00831 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250515001612.0 | ||
| 264 | 0 | _c20051028 | |
| 008 | 200510s 0 0 eng d | ||
| 022 | _a1543-0790 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDöhner, Hartmut | |
| 245 | 0 | 0 |
_aThe use of molecular markers in selecting therapy for CLL. _h[electronic resource] |
| 260 |
_bClinical advances in hematology & oncology : H&O _cFeb 2005 |
||
| 300 |
_a103-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 773 | 0 |
_tClinical advances in hematology & oncology : H&O _gvol. 3 _gno. 2 _gp. 103-4 |
|
| 999 |
_c15799431 _d15799431 |
||